Although internationally available, oral cholera vaccines are not extensively used in public health settings in developing countries where they are most needed. We review oral cholera vaccines that are currently available and in the pipeline including the need for policies that will ensure more ...
The combined effects of continued investments in researching new vaccines and improvements of available vaccines will hopefully shorten the time needed to the development of an effec- tive seasonal and pandemic influenza vaccine suitable for large scale production. Additional material Additional file 1: ...
Several other countries have since given EUA for BNT162b2, Argentina, Chile, Ecuador, Costa Rica, Mexico, Panama, Kuwait, and Singapore among them. Switzerland, Bahrain, and Saudi Arabia have also authorized the vaccine, and on December 31st the WHO granted emergency validation to BNT162b2, th...
Effective vaccines for this group are much needed, as many infectious diseases disproportionately affect the elderly. For example, 70–90% of influenza-related mortalities occur in people older than 65 years232, and COVID-19 is reported to be 62 times more fatal in patients older than 65 ...
Further research is also needed to explore the durability of the immunity induced by each vaccine. We already know that infection by human coronaviruses produces humoral immunological memory that ranges from months to a couple of years, but long-term data on SARS-CoV-2 immunity are still ...
large scale production in the near future. The combined effects of continued investments in researching new vaccines and improvements of available vaccines will hopefully shorten the time needed to the development of an effective seasonal and pandemic influenza vaccine suitable for large scale production....
large scale production in the near future. The combined effects of continued investments in researching new vaccines and improvements of available vaccines will hopefully shorten the time needed to the development of an effective seasonal and pandemic influenza vaccine suitable for large scale production....
Panama, Peru, Paraguay and Uruguay[20],[21],[22],[23],[24],[25],[26],[27]. Only one country out of 17, Mexico, states in their guidelines that PACs regulation is aligned to guidance given in the WHO document[13]. The timelines for review of PACs are defined in 6 of the Latin...
the first COVID-19 vaccines were approved for marketing. At the end of March 2023, over three years after the outbreak of the COVID-19 pandemic, 199 vaccines were in pre-clinical development and 183 in clinical development. The candidate vaccines in the clinical phase are based on the follo...